Adenocarcinoma involving the uterine cervix: Magnetic resonance imaging findings in tumours of endometrial, compared with cervical, origin

Canadian Association of Radiologists Journal

Volumn 57, Issue 1, 2006, Pages 43-48

  Haider, Masoom A ^a,d   Patlas, Michael ^b   Jhaveri, Kartik ^a   Chapman, William ^c   Fyles, Anthony ^d   Rosen, Barry ^c  

^a MOUNT SINAI HOSPITAL   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

Cervix; Endometrium; Neoplasm

Indexed keywords

ADENOCARCINOMA; ARTICLE; ENDOMETRIUM TUMOR; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVALENCE; UTERINE CERVIX;

ADENOCARCINOMA; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BIOPSY; CARCINOMA, ADENOSQUAMOUS; CERVIX UTERI; DATA INTERPRETATION, STATISTICAL; DIAGNOSIS, DIFFERENTIAL; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; FEMALE; HUMANS; HYSTERECTOMY; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; MYOMETRIUM; NEOPLASM INVASIVENESS; NEOPLASM STAGING; REFERENCE STANDARDS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL NEOPLASMS;

EID: 33646947953     PISSN: 08465371     EISSN: 08465371     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Wang SS, Sherman ME, Hildesheim A, Lacey JV, Jr, Devesa S. Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976-2000. Cancer 2004;100:1035-44.
2. Vizcaino AP, Moreno V, Bosch FX, Munoz N, Barros-Dios XM, Parkin DM. International trends in the incidence of cervical cancer: I. Adenocarcinoma and adenosquamous cell carcinomas. Int J Cancer 1998;75:536-45.
3. Levine DA, Hoskins WJ. Update in the management of endometrial cancer. Cancer J 2002;8 Suppl 1:S31-40.
4. Rose PG. Stage IIB-IVA cancer of the cervix. Cancer J 2003;9:404-14.
5. Schilder JM, Stehman FB. Stage Ia-IIa cancer of the cervix. Cancer J 2003;9:395-403.
6. Morris M, Eifel PJ, Lu J, Grigsby PW, Levenback C, Stevens RE, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 1999;340:1137-43.
7. Hricak H, Yu KK. Radiology in invasive cervical cancer. AJR Am J Roentgenol 1996;167:1101-8.
8. Menell JH, Chi DS, Hann LE, Hricak H. The use of MRI in the diagnosis and management of a bulky cervical carcinoma. Gynecol Oncol 2003;89:517-21.
9. Dabbs DJ, Sturtz K, Zaino RJ. The immunohistochemical discrimination of endometrioid adenocarcinomas. Hum Pathol 1996;27:172-7.
10. McCluggage WG, Sumathi VP, McBride HA, Patterson A. A panel of immunohistochemical stains, including carcinoembryonic antigen, vimentin, and estrogen receptor, aids the distinction between primary endometrial and endocervical adenocarcinomas. Int J Gynecol Pathol 2002;21:11-5.
11. Castrillon DH, Lee KR, Nucci MR. Distinction between endometrial and endocervical adenocarcinoma: an immunohistochemical study. Int J Gynecol Pathol 2002;21:4-10.
12. Pavlik EJ, DePriest PD, Gallion HH, Ueland FR, Reedy MB, Kryscio RJ, et al. Ovarian volume related to age. Gynecol Oncol 2000;77:410-2.
13. Dabbs DJ, Geisinger KR, Norris HT. Intermediate filaments in endometrial and endocervical carcinomas. The diagnostic utility of vimentin patterns. Am J Surg Pathol 1986;10:568-76.
14. Staebler A, Sherman ME, Zaino RJ, Ronnett BM. Hormone receptor immunohistochemistry and human papillomavirus in situ hybridization are useful for distinguishing endocervical and endometrial adenocarcinomas. Am J Surg Pathol 2002;26:998-1006.
15. Ansari-Lari MA, Staebler A, Zaino RJ, Shah KV, Ronnett BM. Distinction of endocervical and endometrial adenocarcinomas: immunohistochemical p16 expression correlated with human papillomavirus (HPV) DNA detection. Am J Surg Pathol 2004;28:160-7.